XM non fornisce servizi ai residenti degli Stati Uniti d'America.
G
G

Grifols


News

Grifols SA reports results for the quarter ended in September 30 - Earnings Summary

Grifols SA reports results for the quarter ended in September 30 - Earnings Summary Grifols SA GRFS.OQ reported quarterly adjusted earnings of 16 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 11 cents. The mean expectation of two analysts for the quarter was for earnings of 22 cents per share.
G

Grifols on track to meet 2024 targets as core earnings rise

UPDATE 1-Grifols on track to meet 2024 targets as core earnings rise Adds EBITDA, targets, short-seller context MADRID, Nov 7 (Reuters) - Spanish drugmaker Grifols GRLS .MC> said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in the third quarter from the same period a year ago but its core earnings rose 27% .
G

Grifols on track to meet 2024 targets despite third-quarter profit drop

Grifols on track to meet 2024 targets despite third-quarter profit drop MADRID, Nov 7 (Reuters) - Spanish drugmaker Grifols GRlS.MC said on Thursday it was on track to meet its targets for the year after its net profit fell 7.5% in the third quarter from the same period a year ago. The company booked a net profit of 52 million euros ($56.11 million) in the period on revenues worth 1.79 billion euros.
G

Grifols Reaffirms Guidance For FY 2024

BRIEF-Grifols Reaffirms Guidance For FY 2024 Nov 7 (Reuters) - Grifols SA GRLS.MC : REAFFIRMS GUIDANCE FOR FULL YEAR 2024 Source text: ID:nCNM97VTCt Further company coverage: GRLS.MC (Gdansk Newsroom)
G

Grifols SA <GRFS.OQ> expected to post earnings of 22 cents a share - Earnings Preview

Grifols SA expected to post earnings of 22 cents a share - Earnings Preview Grifols SA GRFS.OQ , GRFS.O is expected to show a rise in quarterly revenue when it reports results on November 7 for the period ending September 30 2024 The Sant Cugat Del Valles Barcelona-based company is expected to report a 8.5% increase in revenue to €1.734 billion from €1.6 billion a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
G

Grifols Gets FDA Approval For Treating Pediatric Surgical Bleeding With Fibrin Sealant

BRIEF-Grifols Gets FDA Approval For Treating Pediatric Surgical Bleeding With Fibrin Sealant Oct 29 (Reuters) - Grifols SA GRLS.MC : RECEIVES FDA APPROVAL TO TREAT SURGICAL BLEEDING IN PEDIATRIC PATIENTS WITH ITS FIBRIN SEALANT SOLUTION Source text: ID:nGNXcdBKsN Further company coverage: GRLS.MC (Gdansk Newsroom)
G

ABB, Barratt Redrow, Ti Fluid Systems

EUROPE RESEARCH ROUNDUP-ABB, Barratt Redrow, Ti Fluid Systems Oct 29 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ABB, Barratt Redrow and Ti Fluid Systems, on Tuesday. HIGHLIGHTS * ABB Ltd ABBN.S : Goldman Sachs cuts to neutral from buy * Barratt Redrow Plc BTRW.L : JP Morgan raises target price to 600p from 560p * Intermediate Capital Group Plc ICGIN.L : Citigroup raises PT to 2610p from 2600p * Ti Fluid Systems TIFS.L : Jeffer
A
B
B
B
C
C
C
D
E
E
E
E
G
H
H
I
K
L
M
P
P
R
S
S
S
S
S
W
G
Y

Spanish stocks - Factors to watch on Oct 29

Spanish stocks - Factors to watch on Oct 29 Oct 29 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Tuesda y . Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: SANTANDER SAN.MC Spain's Santander SAN.MC on Tuesday said its third-quarter net profit rose 12% year-on-year following a solid performance at its main retail business and lower loan loss provisions.
E
G
R
S
B
S

Spanish stocks - Factors to watch on Oct 28

Spanish stocks - Factors to watch on Oct 28 Oct 28 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: SANTANDER SAN.MC Spain's Santander has started a round of job cuts at its British unit as part of the lender's plans to save costs in a competitive banking environment in the United Kingdom, a person familiar with the matter said on Friday.
G
S
S

Grifols Partners With Barda For Testing Of Ocular Immunoglobulin

BRIEF-Grifols Partners With Barda For Testing Of Ocular Immunoglobulin Oct 22 (Reuters) - Grifols SA GRLS.MC : PARTNERS WITH BARDA FOR PROOF-OF-CONCEPT TESTING OF OCULAR IMMUNOGLOBULIN AS TREATMENT FOR SULFUR MUSTARD-INDUCED EYE INJURY ALSO PLANS TO START A PHASE 2 CLINICAL TRIAL OF AN OSIG FOR DRY EYE DISEASE IN THE FIRST HALF OF 2025 SUCCESSFUL P
G

Gigagen Awarded U.S. Barda Contract To Develop Recombinant Polyclonal Antibody Therapies

BRIEF-Gigagen Awarded U.S. Barda Contract To Develop Recombinant Polyclonal Antibody Therapies Oct 3 (Reuters) - Gigagen: AWARDED U.S. BARDA CONTRACT TO DEVELOP RECOMBINANT POLYCLONAL ANTIBODY THERAPIES FOR BOTULINUM NEUROTOXINS AND AN ADDITIONAL BIOTHREAT CONTRACT TO PROVIDE INITIAL COMMITMENT OF $19.6 MILLION AND UP TO $135.2 MILLION OVER SIX-YEA
G

Spanish stocks - Factors to watch on Oct 1

Spanish stocks - Factors to watch on Oct 1 Oct 1 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Tues day . Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: INDRA IDR.MC Indra said on Monday it plans to start a formal process in order to examine various options related to its unit Minsait Payments.
A
G
H
N
S
T
I
S

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say By Andres Gonzalez LONDON, Sept 30 (Reuters) - Canadian fund Brookfield BN.TO reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols GRLS.MC and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday.
G

Grifols plans to invest $402 million in new industrial centre, El Economista says

Grifols plans to invest $402 million in new industrial centre, El Economista says Sept 30 (Reuters) - Spanish drugmaker Grifols GRLS.MC plans to invest 360 million euros ($401.98 million) to build a new industrial plant in Barcelona for its engineering department, newspaper El Economista said on Monday, citing unidentified company sources. Grifols is seeking to centralise operations currently dispersed across different locations, El Economista said.
G

Spanish stocks - Factors to watch on Sept 30

Spanish stocks - Factors to watch on Sept 30 Sept 30 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: AYCO ALCE.SCT Ayco said on Friday the final result of its share capital increase amounted to 6 million euros ($6.70 million).
G
S

Spanish stocks - Factors to watch on Sept 26

Spanish stocks - Factors to watch on Sept 26 Sept 26 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: BBVA BBVA.MC BBVA said on Thursday it will pay a gross cash interim dividend of 0.29 euros ($0.3232) per share on October 10. nFWN3L70Z7 Separately, the bank also said it had approved an issuance of securities contingently convertible into newly issued
G

Spain's CNMV sanctions Grifols and short-seller Gotham City

Spain's CNMV sanctions Grifols and short-seller Gotham City Sept 25 (Reuters) - Spain's stock market regulator CNMV said on Wednesday it was sanctioning short-seller fund Gotham City Research for allegedly manipulating the market for Grifols GRLS.MC shares, and the pharma group for defective financial reporting. Grifols has lost a third of its market value since January when Gotham started releasing several reports accusing it of overstating earnings and understating debt.
G

Grifols Sees No Impact From Sanction Proposed By CNMV On Its Financial Statements

CORRECTED-BRIEF-Grifols Sees No Impact From Sanction Proposed By CNMV On Its Financial Statements Corrects regulator spelling in headline, CNMV not CNVM Sept 25 (Reuters) - Grifols SA GRLS.MC : PENALTY PROPOSED FOR INCIDENTS INDICATED IN CNMV'S REPORT OF CONCLUSIONS DOES NOT EXCEED EUR 1.0 MILLION THIS SANCTION IS NOT MATERIAL AND IT WILL HAVE NO I
G

CNMV Opens Disciplinary Proceedings Against Gotham, GIP, Grifols

BRIEF-CNMV Opens Disciplinary Proceedings Against Gotham, GIP, Grifols Sept 25 (Reuters) - Spain's Comision Nacional del Mercado de Valores (CNMV): OPENS DISCIPLINARY PROCEEDINGS AGAINST GOTHAM AND GENERAL INDUSTRIAL PARTNERS DISCIPLINARY PROCEEDINGS FOR MARKET MANIPULATION IN GRIFOLS SHARES AND FOR BREACH OF PROVISIONS OF REGULATION ON MARKET ABUS
G

Thomas Glanzmann Becomes Non-Executive Chairman Of Grifols

BRIEF-Thomas Glanzmann Becomes Non-Executive Chairman Of Grifols Sept 23 (Reuters) - Grifols SA GRLS.MC : BOARD OF DIRECTORS RESOLVED THAT THOMAS GLANZMANN BECOMES NON-EXECUTIVE CHAIRMAN GLANZMANN WILL CONCENTRATE EXCLUSIVELY ON CHAIRING BOARD IN ORDER TO FURTHER STRENGTHEN CO’S CORPORATE GOVERNANCE, MARKING CLEAR SEPARATION BETWEEN BOARD AND DAI
G



Condizioni

Asset popolari

Disclaimer: le entità di XM Group forniscono servizi di sola esecuzione e accesso al nostro servizio di trading online, che permette all'individuo di visualizzare e/o utilizzare i contenuti disponibili sul sito o attraverso di esso; non ha il proposito di modificare o espandere le proprie funzioni, né le modifica o espande. L'accesso e l'utilizzo sono sempre soggetti a: (i) Termini e condizioni; (ii) Avvertenza sui rischi e (iii) Disclaimer completo. Tali contenuti sono perciò forniti a scopo puramente informativo. Nello specifico, ti preghiamo di considerare che i contenuti del nostro servizio di trading online non rappresentano un sollecito né un'offerta ad operare sui mercati finanziari. Il trading su qualsiasi mercato finanziario comporta un notevole livello di rischio per il tuo capitale.

Tutto il materiale pubblicato sul nostro servizio di trading online è unicamente a scopo educativo e informativo, e non contiene (e non dovrebbe essere considerato come contenente) consigli e raccomandazioni di carattere finanziario, di trading o fiscale, né informazioni riguardanti i nostri prezzi di trading, offerte o solleciti riguardanti transazioni che possano coinvolgere strumenti finanziari, oppure promozioni finanziarie da te non richieste.

Tutti i contenuti di terze parti, oltre ai contenuti offerti da XM, siano essi opinioni, news, ricerca, analisi, prezzi, altre informazioni o link a siti di terzi presenti su questo sito, sono forniti "così com'è", e vanno considerati come commenti generali sui mercati; per questo motivo, non possono essere visti come consigli di investimento. Dato che tutti i contenuti sono intesi come ricerche di investimento, devi considerare e accettare che non sono stati preparati né creati seguendo i requisiti normativi pensati per promuovere l'indipendenza delle ricerche di investimento; per questo motivo, questi contenuti devono essere considerati come comunicazioni di marketing in base alle leggi e normative vigenti. Assicurati di avere letto e compreso pienamente la nostra Notifica sulla ricerca di investimento non indipendente e la nostra Informativa sul rischio riguardante le informazioni sopra citate; tali documenti sono consultabili qui.

Avvertenza sul rischio: Il tuo capitale è a rischio. I prodotti con leva finanziaria possono non essere adatti a tutti. Ti chiediamo di consultare attentamente la nostra Informativa sul rischio.